Latest article
Novo Nordisk presents trial outcomes of Xultophy for kind 2 diabetes
Novo Nordisk said Monday that its type 2 diabetes treatment Xultophy showed superior efficacy in reducing hemoglobin A1c (HbA1c) levels, weight change and lower...
Webinars; Health; Artwork; Comedy; Antiques: Portsmouth Calendar
Posting an event is as easy as 1, 2, 3. Here's how: Create a Patch account and log in to publish your own local...
Health Wearables Vie for $12T Market
Big tech companies and established startups are increasingly obsessed with wearable technology - wrist-worn trackers.
On Tuesday, Amazon announced a variety of new products and...